date,title,source
Oct-26-18,Intellipharmaceutics Regains Compliance with Nasdaq Minimum Shareholders' Equity Listing Requirements,ACCESSWIRE
Nov-05-18,Intellipharmaceutics Announces Resignation of Chief Financial Officer,ACCESSWIRE
Nov-20-18,Intellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and Vietnam,ACCESSWIRE
Nov-21-18,Intellipharmaceutics Reports Exclusive Supply Agreement for its Abuse-Deterrent Oxycodone ER Product Candidate and Four Generic Drug Products in the Philippines,ACCESSWIRE
Nov-26-18,Intellipharmaceutics Announces Receipt of Nasdaq Notice,ACCESSWIRE
Nov-28-18,"The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings",Benzinga
Nov-28-18,Todays Research Reports on Stocks to Watch: IntelliPharmaCeutics International and Bristol-Myers Squibb,ACCESSWIRE
Jan-07-19,Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products,ACCESSWIRE
